Selcuk University Faculty of Dentistry Department of Periodontology
Konya, Selçuklu, 42250, Turkey (Türkiye)
NCT Number: NCT07213752
This study investigated the adjunctive effects of diode laser therapy in smokers with severe periodontitis. Thirty-three patients were randomized to non-surgical periodontal therapy (SRP) with or without diode laser. Clinical parameters and salivary oxidative stress markers (MDA, 8-OHdG) were assessed at baseline, 1, and 3 months. Both groups showed improvements, but SRP+DL resulted in significantly greater reductions in deep pockets, PISA, PESA, PI, and MDA at 3 months. These findings suggest that diode laser therapy may enhance conventional treatment by improving clinical outcomes and reducing oxidative stress in smokers with severe periodontitis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Konya, Selçuklu, 42250, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 940 nm indium-gallium-aluminum-phosphate diode laser (Ezlase, Biolase, USA) with a 400 μm fiber was used in contact mode at 1.5 W, pulse 20/20 ms, 20 s/cm², power density 1.061 W/cm², and 15 J/cm² energy in deep periodontal pockets.
Professional mechanical removal of supragingival plaque and calculus
Subgingival scaling and root planing
Time frame: Through study completion, an average of 3 months.
The probing pocket dept was assessed on six tooth surfaces, inluding the mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual areas of each tooth.
Time frame: Through study completion, an average of 3 months.
PESA represents the total epithelial surface area in periodontal pockets.
Time frame: Through study completion, an average of 3 months.
PISA quantifies the inflamed portion of this surface area by integrating only sites exhibiting BOP, both measured in mm2.
Time frame: Through study completion, an average of 3 months.
Evaluation of salivary malondialdehyde levels.
Time frame: Through study completion, an average of 3 months.
Evaluation of salivary 8-hydroxy-2'-deoxyguanosine levels.
Time frame: Through study completion, an average of 3 months.
For sites with PPD ≥4 mm, site-specific PPD (ssPPD) values was calculated.
Time frame: Through study completion, an average of 3 months.
For sites with PPD ≥4 mm, site spesific CAL (ssCAL) values were also calculated.
Time frame: Through study completion, an average of 3 months.
For sites with PPD ≥4 mm, site-specific PISA (ssPISA) values were calculated.
Time frame: Through study completion, an average of 3 months.
For sites with PPD ≥4 mm, site-specific PESA (ssPESA) values were calculated.
Time frame: Through study completion, an average of 3 months.
The plaque index was assessed on six tooth surfaces, inluding the mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual areas of each tooth.
Time frame: Through study completion, an average of 3 months.
The bleeding on probing index was assessed on six tooth surfaces, inluding the mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual areas of each tooth.
Time frame: Through study completion, an average of 3 months.
The clinical attachment level was assessed on six tooth surfaces, inluding the mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual areas of each tooth.
Time frame: Through study completion, an average of 3 months.
The gingival index was assessed on six tooth surfaces, inluding the mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual areas of each tooth.
Selcuk University
Other
Diode Laser-Assisted Periodontal Therapy Enhances Clinical Outcomes for Deep Periodontal Pockets in Smokers: A Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07312552
Behavior, Inflammasomes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07457892
Behavior, Chemically-Induced Disorders
Erzincan, Province, Turkey (Türkiye)
View Trial DetailsNCT06580431
Behavior, Inflammatory Response
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsNCT05281848
Behavior, Mouth Diseases
Ankara, Turkey (Türkiye)
View Trial Details